References
- Dick G. President’s address. The etiology of multiple sclerosisProc. R. Soc. Med.69, 611–615 (1976).
- Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science251, 70–72 (1991).
- Haubold K, Owens GP, Kaur P, Ritchie AM, Gilden DH, Bennett JL. B-lymphocyte and plasma cell clonal expansion in monosymptomatic optic neuritis cerebrospinal fluid. Ann. Neurol.56, 97–107 (2004).
- Qin YF, Duquette P, Zhang YP, Talbot P, Poole R, Antel J. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J. Clini. Invest.102, 1045–1050 (1998).
- Colombo M, Dono M, Gazzola P et al. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J. Immunol.164, 2782–2789 (2000).
- Baranzini SE, Jeong MC, Butunoi C et al. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol.163, 5133–5144 (1999).
- Qin Y, Duquette P, Zhang Y et al. Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. S. Lab. Invest.83, 1081–1088 (2003).
- Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med.5, 170–175 (1999).
- Zhang Y, Da RR, Hilgenberg LG et al. Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions.J. Neuroimmunol.167, 120–130 (2005).
- Zhang Y, Da RR, Gu WZ et al. Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis. J. Clin. Immunol.25, 252–262 (2005).
- Rawes JA, Calabres VP, Khan OA, DeVries GH. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases. Mult. Scler.3, 363–369 (1997).
- Silber E, Semra YK, Gregson NA, Sharief MK. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit. Neurology58, 1372–1381 (2002).
- Cross SA, Salomao DR, Parisi JE et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann. Neurol.54, 38–50 (2003).
- Sadatipour BT, Greer JM, Pender MP. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis. Ann. Neurol.44, 980–983 (1998).
- Kolln J, Ren HM, Da RR et al. Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis.J. Immunol.177, 5652–5658 (2006).
- Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol.47, 707–717 (2000).
- Bagasra O, Michaels FH, Zheng YM et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis.Proc. Natl Acad. Sci. USA92, 12041–12045 (1995).
- De Stefano N, Matthews PM, Filippi M et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology60, 1157–1162 (2003).